Aug 12, 2020
NS Pharma's VILTEPSO(TM) (viltolarsen) injection Now FDA-Approved in the U.S. for the Treatment of Duchenne Muscular Dystrophy in Patients Amenable to Exon 53 Skipping Therapy
Jun 09, 2020
CureDuchenne Ventures Announces The "CureDuchenne Ventures 2020 Pitch Contest," To Award Two $25,000 Prizes For Novel Ideas In Duchenne Muscular Dystrophy Therapy Development
May 27, 2020
Parent Project Muscular Dystrophy Announces Pediatric Certified Duchenne Care Center, Children's Health and UT Southwestern Medical Center
May 26, 2020
NS Pharma Announces Publication of Clinical Trial Data for Viltolarsen in DMD Patients in JAMA Neurology
May 07, 2020
Duchenne Muscular Dystrophy Market is Anticipated to Grow With a CAGR of 31.8% for the Study Period of 2017-2030: DelveInsight
Apr 29, 2020
CAP-1002 Drug Report 2020: Product Details & Market Outlook to 2030
Apr 01, 2020
Parent Project Muscular Dystrophy Announces First Dual Pediatric & Adult Certified Duchenne Care Center, Kennedy Krieger Institute
Feb 03, 2020
PTC Therapeutics Announces First Publication of Real-World Data Showing Translarnaä (ataluren) Significantly Preserves Ability to Walk for Longer in Children with Duchenne Muscular Dystrophy
Dec 18, 2019
Parent Project Muscular Dystrophy Awards $465,000 Grant to The Ohio State University to Rescue Cardiac Dystrophin & Function in Duchenne Muscular Dystrophy
Dec 13, 2019
MDA Celebrates FDA Approval of Vyondys 53 for Treatment of DMD Amenable to Exon 53 Skipping
Dec 12, 2019
FDA authorizes first test to aid in newborn screening for Duchenne Muscular Dystrophy
Dec 12, 2019
FDA grants accelerated approval to first targeted treatment for rare Duchenne muscular dystrophy mutation
Nov 05, 2019
Dystrogen Therapeutics Announces That Treatment With Dystrophin Expressing Chimeric (DEC) Cells Improves Cardiac Function in Preclinical Duchenne's Study
Oct 17, 2019
Parent Project Muscular Dystrophy Announces Arkansas Children's Hospital as Their 28th Certified Duchenne Care Center
Oct 04, 2019
PTC Therapeutics Announces New Real-World Analysis Demonstrating Translarna(TM) (ataluren) Slows Disease Progression in Patients with Duchenne Muscular Dystrophy
Sep 22, 2019
Adalbert Czerny Award 2019 goes to Dr. med. Ferdinand Knieling for his work on using MSOT for diagnosis of Inflammatory Bowel Disease and Muscular Dystrophy
Sep 17, 2019
PPMD Awards University of Florida $1 Million for Novel Gene Therapy Approach Targeting the Heart
Sep 17, 2019
AskBio Acquires Assets from RoverMed BioSciences, Adds Nanotechnology Precision to Delivery of AAV Gene Therapeutics
Sep 17, 2019
Positive preliminary results from ATL1102 for DMD Phase II trial
Sep 05, 2019
Parent Project Muscular Dystrophy, I-ACT for Children, and Critical Path Institute Host Duchenne Muscular Dystrophy Platform Trial Community Meeting